Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes
Clinical trial NCT05925920 · COMPLETED
Trial details
- NCT number
- NCT05925920
- Sponsor
- Metabolics Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2024-08-12
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.